Apollo Hospitals Enterprise Limited vs Natco Pharma Limited

A side-by-side comparison of Apollo Hospitals Enterprise Limited (APOLLOHOSP) and Natco Pharma Limited (NATCOPHARM) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Apollo Hospitals Enterprise Limited leads APOLLOHOSP vs NATCOPHARM on 9 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability22
  • Growth20
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

58.43
P/E ratio
9.91
13.46
P/B ratio
1.59
0.22%
Dividend yield
0.18%
₹135.04
EPS
₹79.20

Profitability

Even

How efficiently each company turns capital and sales into profit. Higher is better.

20.48%
Return on equity
15.38%
17.31%
Return on capital
15.84%
14.94%
EBITDA margin
35.22%
7.94%
Net margin
34.78%

Growth

APOLLOHOSP takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
14.64%
33.35%
Profit CAGR (3Y)
25.64%

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.14L Cr
Market cap
₹15,404 Cr
₹25,229 Cr
Revenue
₹4,078 Cr
₹2,003 Cr
Net profit
₹1,419 Cr
0.90
Debt / equity
0.08
Apollo Hospitals Enterprise Limited
  • + ["Company has delivered good profit growth of 71.1% CAGR over last 5 years", "Company has delivered good sales growth of 19.0% CAGR over last 5 years"]
  • − ["Stock is trading at 11.98 times its book value"]
Natco Pharma Limited
  • + ["Company has delivered good profit growth of 26.2% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 23.6%", "Company is almost debt free."]
  • − []
Apollo Hospitals Enterprise Limited full analysis Natco Pharma Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.